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Phosphatidylinositol-4,5-bisphosphate (PIP2), one of the key phospholipids, directly interacts with 
several membrane and cytosolic proteins at neuronal plasma membranes, leading to changes in 
neuronal properties including the feature and surface expression of ionotropic receptors. Although 
PIP2 is also concentrated at the dendritic spines, little is known about the direct physiological functions 
of PIP2 at postsynaptic as opposed to presynaptic sites. Most previous studies used genetic and 
pharmacological methods to modulate enzymes that alter PIP2 levels, making it difficult to delineate 
time- or region-specific roles of PIP2. We used chemically-induced dimerization to translocate inositol 
polyphosphate 5-phosphatase (Inp54p) to plasma membranes in the presence of rapamycin. Upon 
redistribution of Inp54p, long-term depression (LTD) induced by low-frequency stimulation was blocked 
in the mouse hippocampal CA3-CA1 pathway, but the catalytically-dead mutant did not affect LTD 
induction. Collectively, PIP2 is critically required for induction of LTD whereas translocation of Inp54p to 
plasma membranes has no effect on the intrinsic properties of the neurons, basal synaptic transmission, 
long-term potentiation or expression of LTD.
Although phosphatidylinositol-4,5-bisphosphate (PIP2) is a substrate for the generation of the second messengers 
inositol triphosphate (IP3) and diacylglycerol (DAG), PIP2 itself also interacts with membrane and cytosolic pro-
teins to regulate a number of cellular processes in neurons. It is suggested that PIP2 directly controls the activity of 
ion channels and transporters1, which results in drastic changes in neuronal properties2, 3. For example, PIP2 bind-
ing regulates the activities of the KCNQ and inward-rectifying potassium channels (Kirs) that determine neu-
ronal excitability3–5. Adaptor protein-2 (AP-2), which interacts with PIP2, is causally involved in the trafficking 
of synaptic vesicles and neurotransmitter receptors through clathrin-mediated endocytosis6, 7. Indeed, exocytosis 
and recycling of synaptic vesicles at presynaptic sites are affected by the amount of available PIP21, 8. Depletion of 
PIP2 results in a smaller pool of readily releasable synaptic vesicles as well as delayed endocytosis and recycling7.
Despite the large volume of evidence for the actions of PIP2 at presynaptic sites, we have only limited knowl-
edge on the physiological roles of PIP2 at postsynaptic sites, although PIP2 is also concentrated at the plasma 
membrane of dendrites9. At postsynaptic sites, endocytosis of membrane proteins maintains surface expression of 
N-methyl-D-aspartate receptors (NMDARs) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid recep-
tors (AMPARs)10. It was previously shown that PIP2 facilitates the surface expression of NMDARs in cultured 
cortical neurons while loss of PIP2 enhances clathrin-dependent NMDAR internalization by promoting cofilin 
depolymerization of the actin cytoskeleton11. Internalization of AMPAR by cultured hippocampal neurons is 
blocked by a lack of synaptojanin that mediates PIP2 dephosphorylation12.
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Genetic modification of enzymes that alter PIP2 levels affects properties related to NMDAR-dependent syn-
aptic plasticity, such as long-term depression (LTD)13–15. For example, deletion of phosphatidylinositol 3-kinase 
γ (PI3Kγ) which phosphorylates PIP2 to generate PIP3, impairs LTD16. However, such previous studies reported 
conflicting results and thus do not provide unequivocal evidence supporting whether and how PIP2 controls syn-
aptic plasticity14–16. This ambiguity is likely due to methodological differences among different studies, as mod-
ulation of PIP2 levels was achieved by genetic and pharmacological modifications of PIP2-metabolic enzymes, 
such as synaptojanin 1, phosphatase and tensin homolog (PTEN), phospholipase C (PLC), and phosphatidylin-
ositol 4-phosphate 5-kinases (PIP5Ks). Because these enzymes affect other proteins as well as control PIP2 lev-
els17–19, the possibility cannot be excluded that the findings of previous studies resulted from unintended effects 
of PIP2-metabolic enzymes on other signaling molecules rather than on PIP2. In addition, genetic modification 
can lead to developmental compensatory effects and a number of potentially non-physiological outcomes towing 
to the protracted time courses of the modification. Although pharmacological approaches allow for elucidation 
of time-specific effects, it is almost impossible to distinguish between the roles of PIP2 in pre- or post-synapses 
because pharmacological agents diffuse throughout brain tissue.
To resolve the discrepancy and to obtain better insight into the direct effects of PIP2 on LTD, we devel-
oped a means to acutely deplete PIP2 in hippocampal neurons using chemically-induced dimerization (CID), 
which utilized the heterodimerization of the domain from the FK506-binding protein (FKBP) and the FKBP 
rapamycin-binding (FRB) domain from the mechanistic target of rapamycin (mTOR). A PIP2-specific phos-
phatase, inositol polyphosphate 5-phosphatase (Inp54p), was translocated to the plasma membrane of neurons 
in the presence of rapamycin and promptly depleted PIP2, as previously shown in other cell types20–23. Using 
this CID system, we then determined whether PIP2 controls synaptic transmission and plasticity in the Schaffer 
collateral-CA1 pathway in mouse hippocampus. We also elucidated the time frame during which PIP2 is required 
for NMDAR-dependent LTD. Our results indicated that PIP2 is necessary for the induction of LTD but not for 
LTD expression or synaptic transmission.
Results
CID induces acute reduction in membrane PIP2 levels. To elucidate the physiological roles of PIP2 at 
postsynaptic neurons by precisely modulating membrane PIP2 levels of live neurons in hippocampal slices, we 
adapted a CID system that has been previously used mainly for non-neuronal cell types21, 22. For in situ CID, cells 
need to express two components, membrane-targeted proteins and PIP2-specific phosphatases, that allow rapid 
metabolism of PIP2 within the plasma membrane22. Although this CID system has been used in several cell types, 
it would be difficult to introduce two components at an equimolar ratio into individual neurons and extend this 
system to brain slices and even intact animals24, 25. Thus, we designed a new viral construct using the 2 A peptide 
sequence from the insect Thosea asigna virus (T2A) to link the two components26: The enhanced cyan fluorescent 
protein (eCFP) or the enhanced green fluorescent protein (eGFP) sequence fused to the N-terminus of FKBP-
Inp54p (FKBP-Inp54p) was linked to Lyn11-FRB (LDR), a membrane-anchored FRB, via a T2A-linked sequence 
(LDR-T2A-Inp54p) (Fig. 1a).
We examined whether the application of rapamycin could lead to recruitment of Inp54p to the plasma mem-
brane and subsequently reduce of the membrane PIP2 level. Live-cell imaging of HEK293T cells revealed that 
FKBP-Inp54p normally remained in the cytosolic space but moved to the plasma membrane within 3 min of 
rapamycin treatment (Fig. 1b,c). We also co-transfected individual HEK293T cells with the pleckstrin homology 
domain of PLC-δ, PIP2-binding domain tagged with either eGFP or mCherry (PH-domain)27, and thereby tested 
whether the membrane-targeted Inp54p was able to metabolize PIP2. As expected, rapamycin treatment resulted 
in translocation of the PH-domain from the plasma membrane to the cytosol, indicating that membrane-bound 
PIP2 was readily depleted by Inp54p within 3 min. We next examined whether the CID moved to the cell mem-
brane and subsequently reduced membrane PIP2 levels in the hippocampal neurons. Prior to rapamycin treat-
ment, FKBP-Inp54p was widely distributed in soma and neurites of neurons, while the PH-domains were largely 
located in the plasma membrane. Rapamycin treatment caused FKBP-Inp54p to translocate from cytosolic areas 
to the plasma membrane. The PH-domains that were present in soma and neurites were released into the cyto-
solic compartment. These results indicated that PIP2 is rapidly metabolize by FKBP-Inp54p and rapamycin treat-
ment (Fig. 1d,e).
To implement the CID system in intact neural circuits, we sought to produce viruses expressing 
LDR-T2A-Inp54p. Because the insert size ( > 5 kb) surpassed the packaging limit of adeno-associated viruses, 
we attempted to express LDR-T2A-Inp54p using a lentivirus that allows for long-term expression as well as 
for packaging of long genomes28. We produced a lentivirus containing LDR-T2A-Inp54p by co-transfecting 
LDR-T2A-Inp54p, VSVg, gag and pol constructs into HEK293T cells. The harvested virus successfully infected 
HEK293T cells (Fig. 2a). This virally expressed LDR-T2A-Inp54p also translocated from the cytosol to the plasma 
membrane within 3 min of rapamycin treatment, validating the effectiveness of our LDR-T2A-Inp54p virus 
(Fig. 2a).
Neural circuits in the hippocampal CA1 undergo extensive synaptic plasticity, which is subject to a number 
of neuronal modifications, such as trafficking of synaptic vesicles at presynaptic sites and transmitter receptors at 
postsynaptic sites29–32. Thus, pyramidal neurons innervated by the Schaffer collateral pathway are well-suited to 
examining the direct roles of PIP2 in synaptic plasticity. We infused the lentivirus into the CA1 region of the hip-
pocampus in live mice on postnatal day 21 and waited for 7 to 10 days for full expression of LDR-T2A-Inp54p33, 34. 
As revealed by fluorescent eCFP signals, Inp54p was expressed selectively in the cell bodies and dendrites of 
CA1 pyramidal neurons (Fig. 2b). We also monitored the movement of FKBP-Inp54p after rapamycin treatment 
in hippocampal slices. In agreement with our in vitro data (Fig. 2a), bath application of rapamycin resulted in 
decreased expression of FKBP-Inp54p in cytosolic spaces (Fig. 2c). These results support the notion that treat-
ment of rapamycin could induce the translocation of Inp54p in brain tissues as well as in cultured cells.
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CID-induced manipulation of PIP2 has no effect on intrinsic properties or synaptic transmission 
in pyramidal neurons. PIP2 binds to ion channels, including the KCNQ family and Kirs, and thereby reg-
ulates neuronal activities35, 36. If this is also the case in neurons, the CID-induced manipulation of PIP2 would 
potentially affect the intrinsic properties of hippocampal CA1 pyramidal neurons. To examine this possibility 
we first showed that rheobase, the smallest current amplitudes required to elicit a single spike (Fig. 3a), and 
the number of spikes elicited upon injection of current (Fig. 3b) remained unaltered before and after addition 
of rapamycin to uninfected CA1 pyramidal neurons, suggesting that rapamycin itself did not change intrinsic 
properties, such as membrane excitability, in CA1 pyramidal neurons. Then, we examined the intrinsic properties 
of CA1 neurons infected with lentivirus containing LDR-T2A-Inp54p. Because the level of membrane PIP2 did 
not decrease in the presence of Inp54p alone without rapamycin (Fig. 1), we examined whether translocation of 
FKBP-Inp54p by rapamycin could affect membrane excitability. The administration of rapamycin did not alter 
rheobase or the number of spikes following the injection of current, at least within the time window that we 
monitored in the current study (Fig. 3c,d). It is conceivable that the resting membrane potential (RMP) would 
be altered by our manipulation because a number of the ion channels that maintain the RMP are controlled by 
PIP237. Inconsistent with this possibility, rapamycin-triggered translocation of FKBP-Inp54p did not affect the 
Figure 1. Validation of chemically induced dimerization for PIP2 depletion using a single plasmid, LDR-T2A-
Inp54p. (a) Schematic representation of the construct of the plasma membrane PIP2 depletion system using a 
viral T2A peptide sequence linker. (b) Representative images of a HEK293T cell expressing LDR, FKBP-Inp54p 
(red), and PH-domain (green) before (−) and after (+) treatment with 100 nM rapamycin. Areas outlined 
with yellow lines represent the cytoplasmic region of interest (ROI). Scale bars: 5 μm. (c) Mean fluorescence 
intensity of ROI in cells expressing LDR, FKBP-Inp54p, and PH-domain before and after treatment with 
100 nM rapamycin in HEK293T cells (FKBP-Inp54p: 47.63 ± 4.30 vs. 33.53 ± 2.32, ***p < 0.001; PH-domain: 
23.11 ± 4.09 vs. 39.92 ± 4.88, **p < 0.01, N = 4, n = 20, Wilcoxon test). (d) A representative neuron expressing 
LDR, FKBP-Inp54p (red), and PH-domain (green) before (−) and after (+) 100 nM rapamycin treatment. 
Areas outlined with yellow lines represent the cytoplasmic region of interest (ROI). Scale bars: 10 μm. (e) Mean 
fluorescence intensity of ROI in hippocampal neurons expressing LDR, FKBP-Inp54p, and PH-domain before 
and after 100 nM rapamycin treatment (FKBP-Inp54p: 47.80 ± 0.60 vs. 30.55 ± 2.57, **p < 0.01; PH-domain: 
21.54 ± 2.37 vs. 40.23 ± 1.26, **p < 0.01, N = 2, n = 6, Wilcoxon test).
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RMP in LDR-T2A-Inp54p infected neurons (Fig. 3e). Thus, the intrinsic properties of hippocampal neurons are 
largely indifferent to dynamic ranges of PIP2.
Given the previous evidence indicating that the abundance of glutamate receptors in the plasma membrane 
could be differentially modulated by altered PIP2 levels11, 14, we elicited excitatory postsynaptic currents (EPSCs) 
in CA1 neurons while stimulating the Schaffer collateral pathway of hippocampal slices prepared from mice that 
had been infused with lentivirus containing LDR-T2A-Inp54p. Subsequently, we measured AMPAR-mediated 
and NMDAR-mediated EPSCs as previously described38 (Fig. 4a) and calculated the ratios of AMPAR- to 
NMDAR-EPSCs (A/N ratio), which is indicative of the nature of the synaptic transmission9, 11, 14. We did not 
observe any significant rapamycin-induced alteration in the A/N ratio of the CA1 pyramidal neurons infected 
with lentivirus containing LDR-T2A-Inp54p, and the A/N ratio in the infected neurons was comparable to the 
values obtained from the uninfected neurons (Fig. 4a,b). The observed absence of effect on synaptic transmission 
was surprising, given the previous reports suggesting that PIP2 could control the activity of either NMDARs 
or AMPARs11, 39. Because the constant A/N ratio might have resulted from concurrent shifts in AMPAR- and 
NMDAR-EPSCs, we continuously monitored the AMPAR-EPSCs that were recorded at a holding potential of 
–70 mV but failed to observe any change in AMPAR-EPSC amplitudes despite rapamycin treatment (Fig. 4c,d). 
Thus, synaptic transmission is unlikely to be affected by the PIP2 dephosphorylation per se. Interestingly, our 
results are inconsistent with those observed in previous studies based on relatively long-term manipulations of 
PIP2-regulating enzymes14.
LTD induction affected by CID translocation. LTP impairment in aged animals has been attributed, 
at least in part, to reduced levels of PIP240. To address this possibility, we examined whether acute depletion of 
PIP2 impaired synaptic plasticity, as has been shown in aged mice. We first assessed the effect of rapamycin on 
LTP at the concentration we had used for dephosphorylation of PIP2, as LTP can be abolished in the presence 
of rapamycin, likely via inhibition of mTOR signaling41. We applied rapamycin (100 nM) 3 min before the start 
of baseline recording, but did not detect a significant difference in induction or expression of LTP induced by 
pairing presynaptic stimulation (2 Hz, 80 pulses) with postsynaptic depolarization (0 mV) (Fig. 5a). Importantly, 
the magnitude of LTP in the neurons infected with the lentivirus containing LDR-T2A-Inp54p was comparable 
to that in uninfected neurons, indicating that rapamycin treatment and the resultant dephosphorylation of PIP2 
Figure 2. Viral expression of LDR-T2A-Inp54p in HEK293T cells and a mouse brain. (a) Example images of 
a HEK293T cell infected with lentivirus containing the chemically induced PIP2 depletion system before and 
after treatment with 100 nM rapamycin. Scale bar: 10 μm. (b) Experimental timeline for virus infusion and 
electrophysiological analysis (left). Representative images of lentiviral LDR-T2A-Inp54p expression in the 
mouse hippocampus showing DAPI (blue) and LDR-T2A-Inp54p expression (red) (middle). The magnified 
image shows the red rectangular area in the middle image (right). Scale bars: 100 μm (middle) and 50 μm 
(right). (c) Translocation of FKBP-Inp54p in brain slices with (+) and without (−) bath application of 100 nM 
rapamycin. FKBP-Inp54p (red), DAPI (blue) are shown. Scale bars: 5 μm.
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via CID had no significant impact on LTP (Fig. 5b). Thus, induction and maintenance of LTP does not causally 
rely on normal levels of PIP2, at least in the CA1 pyramidal neurons, while chronic reduction of PIP2 levels can 
result in impairment of LTP40.
PIP2 is an important factor in controlling NMDAR-dependent LTD in the hippocampus. For example, inhi-
bition of PTEN, which dephosphorylates PIP3 to generate PIP2, interferes with LTD induction14. Moreover, the 
activity of PIP5Kγ661, the major PIP2-producing enzyme in the brain, is required for the endocytosis of AMPA 
receptors during LTD15. However, previous studies were unable to provide sufficient evidence to indicate that PIP2 
plays a direct role because PIP2 levels in these studies were controlled by overexpressing PIP2-modifying proteins. 
As exemplified for LTP, it remains unclear whether dephosphorylation of PIP2 could lead to impairment of LTD. 
To re-confirm this notion, we induced LTD with low-frequency stimulation (LFS, 1 Hz, 900 pulses) after rapamy-
cin treatment in uninfected and infected hippocampal CA1 neurons. As expected, we observed that the rapamy-
cin treatment did not affect LTD in uninfected hippocampal neurons (Fig. 6a). However, rapamycin treatment 
blocked LTD in neurons infected with lentivirus containing LDR-T2A-Inp54p, as compared with uninfected 
control neurons (Fig. 6b). These results indicated that LTD occurring in the CA3-CA1 synapse is inhibited by the 
rapamycin induced translocation of Inp54p.
To verify that the blockade of LTD induction resulted from the PIP2 decrease, we used the catalytically dead 
mutant LDR-FKBP-Inp54p(D281A)22. We tested whether the translocation of FKBP-Inp54p(D281A) affected 
membrane PIP2 levels. However, rapamycin treatment did not result in the translocation of the PH-domain 
from the plasma membrane to the cytosol, indicating that membrane-bound PIP2 was not reduced by 
Inp54p(D281A) in HEK293T cells (Fig. 6c). LTD was induced normally in CA1 pyramidal neurons expressing 
FKBP-Inp54p(D281A) in the presence of rapamycin, which does not dephosphorylate PIP2 (Fig. 6d,e). These 
results indicated that the blockade of LTD by the translocation of FKBP-Inp54p results from the decrease of PIP2 
although we did not directly show the depletion of PIP2.
The CID system allows for the control of PIP2 levels for several minutes after application of rapamycin 
(Fig. 1), which can impart rapid temporal control of physiological actions induced by PIP2. By applying rapa-
mycin after the induction of LTD, we sought to determine whether membrane PIP2 is also required for LTD 
Figure 3. Lack of effect of rapamycin or acute reduction of PIP2 on neuronal excitability. (a) Mean rheobases 
in uninfected CA1 neurons with and without rapamycin (Rapamycin (−), 80.84 ± 8.02 pA, N = 4, n = 5 vs. 
Rapamycin (+), 73.80 ± 9.32 pA, N = 3, n = 6, p > 0.1, Mann-Whitney U-test). (b) The number of spike firings 
at the indicated current steps in uninfected CA1 neurons. (c) Mean rheobases in CA1 neurons expressing 
LDR-T2A-Inp54p with and without rapamycin. (Rapamycin (−), 82.67 ± 9.32 pA, N = 2, n = 5 vs. Rapamycin 
(+), 76.05 ± 11.8 pA, N = 2, n = 4, p > 0.1, Mann-Whitney U-test) (d) The number of spike firings at the 
indicated current steps in CA1 neurons expressing LDR-T2A-Inp54p. (e) Resting membrane potentials 
(RMPs) of hippocampal neurons before and after rapamycin treatment (Uninfected neurons: Rapamycin (−) 
−69.55 ± 0.55 mV vs. Rapamycin (+) −70.17 ± 1.12 mV, N = 3, n = 10, p > 0.1; Infected neurons: Rapamycin 
(−) −71.11 ± 0.59 mV vs. Rapamycin (+) −70.59 ± 0.97 mV, N = 3, n = 9, p > 0.1, Paired T-test). Error bars 
show mean ± SEM.
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expression. When rapamycin was perfused after LFS and the ensuing induction of LTD, however, we detected 
no significant change in the magnitude of LTD in neurons infected or uninfected with lentivirus containing 
LDR-T2A-Inp54p (Fig. 6f,g). This finding argues against the possible involvement of PIP2 in the expression phase 
of LTD. Collectively, the results of our rapid manipulation of PIP2 levels revealed that membrane PIP2 is an essen-
tial factor in the induction of LTD, likely through the direct action of the phospholipid rather than via the IP3 and 
DAG generated from PIP2.
Discussion
We developed and used CID in hippocampal circuits to resolve the existing disparate observations about direct 
effects of PIP2 on neural and synaptic functions. Contrary to previous findings, this study indicates that PIP2 is 
critically and selectively necessary for LTD induction but not for neuronal excitability, synaptic transmission, 
LTP expression or LTD expression. In addition, we proved the efficacy of the new method whereby PIP2 levels are 
controlled through immediate translocation of PIP2-modulating enzymes to dephosphorylate PIP2.
Previous studies have critical limitations in elucidating the direct physiological roles of PIP2 in synaptic plas-
ticity in that most relied on genetic manipulation of PIP2-metabolizing enzymes in the brain tissues and animal 
models9, 14, 15. The long-term modulation of PIP2-modifying enzymes could potentially produce compensatory 
effects. It might also produce untoward alteration of the other signaling molecules besides membrane-bound 
PIP2, which should compound the physiological or behavioral consequences derived from modulation of PIP2 
levels. Ectopic expression of the enzymes does not allow a determination of the timeframe during which PIP2 can 
exert its action on each stage of synaptic plasticity. Furthermore, pharmacological modulation of PIP2-modifying 
Figure 4. Lack of effect of rapamycin or acute reduction of PIP2 on excitatory synaptic transmission. (a) 
Representative traces of evoked EPSCs (−70 mV holding potential for AMPAR-EPSCs and +40 mV holding 
potential for NMDAR-EPSCs). AMPAR- (lower large red circles) and NMDAR-dependent EPSCs (upper small 
red circles) were measured. (b) Mean AMPAR/NMDAR ratios for each group (Rapamycin (−): uninfected 
5.08 ± 0.92, N = 7, n = 11 vs. infected 5.34 ± 0.76, N = 5, n = 7, p > 0.1; Rapamycin (+): uninfected 5.39 ± 0.53, 
N = 6, n = 12 vs. infected 5.73 ± 1.06, N = 5, n = 6, p > 0.1, Mann-Whitney U-test). (c) Time course of the 
normalized amplitudes of EPSCs in hippocampus CA1 neurons. Amplitudes of EPSCs are normalized to 
baseline levels that were recorded for 10 min before treatment with rapamycin (gray bar). Inserts: representative 
traces with color- matched time points. (d) Mean EPSC amplitudes in CA1 neurons for each group. (Rapamycin 
(−): uninfected 100.23 ± 2.17%, N = 4, n = 5 vs. infected 104.93 ± 2.58%, N = 4, n = 4, p > 0.1; Rapamycin (+): 
uninfected 91.28 ± 15.68%, N = 4, n = 5 vs. infected 105.42 ± 12.13%, N = 4, n = 4, p > 0.1, Mann-Whitney 
U-test). Error bars show mean ± SEM.
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enzymes has the caveats of potential off-target effects and diffusion time, particularly problematic in brain 
tissues25.
We adopted the CID system and further developed it for a use in brain slices, which allowed us to overcome 
the aforementioned limitations and resolve conflicting observations for direct roles of PIP2 in synaptic transmis-
sion and synaptic plasticity in the CA114–16.
Although rapamycin has been shown to block LTP41, we ruled out the possibility that our brief treatment with 
rapamycin at the concentration used (100 nM for 3 min) interferes with synaptic plasticity by observing intact 
synaptic transmission and normal development of LTP. These data, along with immunohistochemical results, 
verify the specificity and efficacy of the CID system for temporal control of PIP2 level without affecting synaptic 
features.
We provided substantial but indirect evidences indicating that our CID system could acutely dephosphorylate 
PIP2 in brain slices: 1) rapamycin could result in translocalization of FKBP-Inp54p in CA1 neurons. 2) when 
the catalytically-dead mutant of Inp54p was used, rapamycin treatment induced the similar redistribution of 
FKBP-Inp54p but did not affect LTD. Although these findings support the possibility that PIP2 is manipulated 
by CID in brain slices, further studies including quantitative immunostaining for PIP2 would be required to 
ascertain that PIP2 is reduced by the used CID method and to analyze changes in the amount of PIP2 residing 
particularly in the brain slices.
We re-assessed at the hippocampal circuit level whether PIP2 could directly control neuronal and synap-
tic features using CID. The acute dephosphorylation of PIP2 did not produce a significant alteration in neu-
ronal excitability and synaptic transmission, although it was previously reported that the activity of NMDARs or 
AMPARs is regulated by appropriate levels of PIP2. However, it remains unclear what caused the discrepancies 
between our and previous studies. Activity of PIP2-modifying enzymes, such as PTEN, would regulate individ-
ual glutamatergic receptors by altering the channel activity or synaptic distribution of receptors14. If this is the 
case, the previously observed changes in synaptic transmission would have resulted from secondary effects of 
PIP2-modifying enzymes rather than direct PIP2 decrease. In aged mice, elevated levels of Ca2+ lead to gradual 
release of the myristoylated alanine-rich C-kinase substrate from the membrane and subsequent loss of PIP2, 
which results in impairment of PLCγ signaling and LTP40. However, we failed to detect any changes in LTP at the 
CA3-CA1 synapse elicited by stimulation of the Schaffer collateral pathway. Importantly, we observed impair-
ment in NMDAR-dependent LTD when PIP2 was dephosphorylated selectively at the postsynaptic CA1 neurons 
by targeted viral infusion. These results clarify previous conflicting findings on the role of PIP2 signaling for post-
synaptic function and plasticity. Furthermore, our CID enabled us to examine which phase of LTD is dependent 
upon the basal levels of PIP2 by temporally regulating administration of rapamycin, revealing the necessity of 
PIP2 for induction of LTD but not expression. To our knowledge, this is the first study demonstrating that a basal 
amount of PIP2 at the postsynaptic sites is required for LTD induction alone.
The detailed molecular mechanisms underlying reduced LTD induction upon PIP2 manipulation 
remain unclear. One possibility is blockade of AMPAR endocytosis during LTD induction. The binding of 
clathrin-adaptor, AP-2, to membrane PIP2 is essential for triggering clathrin-mediated AMPAR endocytosis 
Figure 5. Induction and expression of pairing protocol-induced LTP were not affected by rapamycin or acute 
reduction of PIP2. (a) Normalized EPSC amplitudes before and after LTP induction. Amplitudes of EPSCs are 
normalized to baseline levels that were recorded for 10 min before the pairing protocol (arrow). Rapamycin 
treatment occurred prior to the beginning of the recording. Inserts: representative traces of evoked EPSCs with 
color- matched time points (b) Mean EPSC amplitudes before and after LTP induction in CA1 neurons for each 
group. (Basal: uninfected 105.09 ± 2.76%, N = 5, n = 5 vs. infected 107.83 ± 1.31%, N = 4, n = 4, p > 0.1, LTP: 
uninfected 156.16 ± 17.48%, N = 5, n = 5 vs. infected 148.60 ± 14.98%, N = 4, n = 4, p > 0.1, Mann-Whitney 
U-test). Error bars show mean ± SEM.
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induced by LTD15. Reduction of membrane PIP2 might impede this interaction and decrease surface expression 
of AMPAR. Further detailed investigations will be required to clarify these issues.
There is mounting evidence for the critical roles of LTD in cognitive functions42–44. In fact, NMDAR-dependent 
LTD is reported to be involved in the development of behavioral flexibility16, 45, episodic-like memory46, 
and immediate memory of a novel context47. While those previous studies had suggested the causal role of 
NMDAR-dependent LTD in mental functions, including updating and flexibility of spatial and emotional mem-
ory, there have been no effective means to modulate LTD in a time- and circuit-specific fashion. It would be 
extremely interesting to discover whether and how temporal regulation of NMDAR-dependent LTD has any 
significant impact on specific types of memory-related behavior. Further investigations using the CID system are 
underway to elucidate the behavioral and physiological underpinnings of PIP2- and LTD-mediated regulation at 
the circuit and organism levels.
PIP2 deficiencies were observed in pathophysiological situations, like brain aging and Alzheimer’s disease 
(AD)40, 48. Although these are likely to be chronic situations, it is possible to examine the chronic effects of PIP2 
decrease because the CID complex induced by rapamycin is irreversible. Reducing PIP2 levels acutely and in vivo 
via CID may provide a relevant model to identify cellular mechanism.
Figure 6. Acute PIP2 reduction disrupted induction but not expression of LTD. (a) Normalized EPSC 
amplitudes when PIP2 depletion occurred before the LTD induction. Rapamycin treatment was made prior 
to the beginning of the recording. Inserts: representative traces with color- matched time points. (b) Mean 
EPSC amplitudes before and after LTD induction in CA1 neurons for each group (Rapamycin (−): uninfected 
101.44 ± 1.84%, N = 7, n = 9 vs. infected 103.15 ± 1.87%, N = 5, n = 5, p > 0.1; Rapamycin (+): uninfected 
66.62 ± 6.91%, N = 7, n = 9 vs. infected 94.22 ± 9.62%, N = 5, n = 5, *p < 0.05, Mann-Whitney U-test). (c) 
Representative images of a HEK293T cell expressing LDR, FKBP-Inp54p(D281A) (red), and PH-domain 
(green) before and after 100 nM rapamycin treatment. Scale bars: 5 μm. (d) Normalized EPSC amplitudes from 
FKBP-Inp54p(D281A)-expressing neurons. Rapamycin treatment was made prior to the beginning of the 
recording. Inserts: representative traces with color- matched time points. (e) Mean EPSC amplitudes before and 
after LTD induction in CA1 neurons for each group (Rapamycin (−): uninfected 101.73 ± 4.10%, N = 4, n = 4 
vs. infected 95.64 ± 2.18%, N = 3, n = 5, p > 0.1; Rapamycin (+): uninfected 56.40 ± 14.27%, N = 4, n = 4 vs. 
infected 47.42 ± 8.68%, N = 3, n = 5, p > 0.1, Mann-Whitney U-test). (f) Normalized EPSC amplitudes when 
PIP2 depletion occurred during the LTD expression. Rapamycin treatment occurred during LTD expression 
(gray bar). Inserts: representative traces with color- matched time points. (g) Mean EPSC amplitudes before and 
after the LTD induction in CA1 neurons for each group (Rapamycin (−): uninfected 104.61 ± 2.89%, N = 5, 
n = 6 vs. infected 102.22 ± 2.79%, N = 7, n = 7, P > 0.1; Rapamycin (+): uninfected 63.24 ± 10.47% N = 5, n = 6 
vs. infected 52.78 ± 11.88%, N = 7, n = 7, p > 0.1, Mann-Whitney U-test). Error bars show mean ± SEM. All 
amplitudes of EPSCs are normalized to basal recording for 10 min before LTD induction by LFS (upper black 
bar).
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Given the high affinity of rapamycin for its protein-binding partners (Kd = 0.2 nM for rapamycin–FKBP bind-
ing and Kd = 12 nM for FKBP-rapamycin-FRB)49, rapamycin-inducible tools for manipulating signal transduction 
would be considered irreversible. The irreversibility would preclude extensive usage of this CID for sequential 
studies to assess physiological roles and molecular mechanisms of PIP2 for synaptic plasticity in a time- and 
phase-dependent manner. Recently, photocleavable rapamycin and the dual CID system were developed for tem-
poral and spatial control of enzymatic activity50–52. If reversible rapamycin derivatives are used to construct a 
novel CID for future investigations, one can gain further molecular insights into the roles of PIP2 or phosphoinos-
itide metabolites in synaptic plasticity and animal behavior.
In conclusion, we developed CID system and identified that appropriate levels of PIP2 at plasma membrane 
are critically required for induction of LTD, but not expression. Future studies using this CID will provide ample 
mechanistic insights into functional roles of PIP2 or phosphoinositide metabolites at the neural circuit and poten-
tially organismic levels.
Methods
Animal. C57BL/6 mice were housed under a 12-hour light/dark cycle and given ad libitum access to food 
and water. All procedures for animal experiments were approved by the ethical review committee of POSTECH 
(Pohang University of Science & Technology), Korea and performed in accordance with the relevant guidelines.
DNA constructs. To generate LDR-T2A-Inp54p, Lyn11-targeted FRB (LDR) (plasmid #20147) and CF-Inp54p 
(plasmid #20155) were obtained from Addgene. As a backbone vector, pCDH-EF1-MCS-T2A-copGFP vector 
was used. The PCR fragment containing the LDR plus T2A sequence was digested with XbaI and PstI and ligated 
into the backbone vector between XbaI and PstI. Subsequently, the PCR fragment of CF-Inp54p was digested 
with PstI and SalI and was inserted into the LDR-T2A sequence containing vector. eCFP was replaced by eGFP 
amplified from EGFP-N1. In the LDR-T2A-Inp54p construct, Inp54p was superseded by the PCR fragment of 
Inp54p(D281A) from CF-Inp(D281A) (Addgene, plasmid 20156). PH-GFP (plasmid #21179) and PH-mCherry 
(plasmid #36075) were purchased from Addgene.
Cell culture and transfection. HEK293T cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS; Hyclone, Logan, UT) and penicillin–streptomy-
cin (100 U/ml penicillin–100 μg/ml streptomycin) and incubated under an atmosphere of 5% CO2 at 37 °C. 
Transfections were performed using Lipofector Q (AptaBio, South Korea) according to the manufacturer’s 
instructions. The fluorescence images were obtained 24 h after transfection. HEK293T cells were infected with 
lentivirus containing LDR-T2A-Inp54p and then 3 days after infection, cells were examined.
Hippocampal neuron culture, transfection, and immunocytochemistry. Primary hippocampal 
neurons dissected from the brains of postnatal day 1 (P1) of C57BL/6 mice were plated on poly-L-lysine (Sigma, 
St. Louis, MO) coated coverslips. Neurons were maintained in neurobasal medium (Invitrogen, Carlsbad, CA) 
supplemented with B27 (Invitrogen), 5 mM L-glutamine (Sigma) and 1% penicillin–streptomycin (Invitrogen) 
under an atmosphere of 5% CO2 at 37 °C. Neurons were transfected with Calcium Phosphate Transfection Kit 
(Invitrogen) following the previously described methods53. 100 nM rapamycin (LC laboratories, Woburn, MA) 
were applied for 3 min.
Virus production. Lentiviral constructs were cotransfected with vesicular stomatitis virus glycoprotein, gag 
and pol constructs in HEK293T cells by Lipofector Q (AptaBio). 72 h after transfection, viral media were har-
vested. To remove cellular debris, harvested media were centrifuged at 1,500 rpm for 5 min. Supernatant was fil-
tered through a 0.45 μm syringe filter (Sartorius stedim, Germany) and then concentrated by ultracentrifugation 
using an SW28 rotor (Beckman Coulter, Brea, CA) at 25,000 rpm for 120 min at 4 °C.
Stereotaxic injection of lentivirus. C57BL/6 male mice (P21) were anesthetized with ketamine and xyla-
zine mixture by an intraperitoneal injection and placed in a small animal stereotaxic frame (David Kopf instru-
ments, Tujunga, CA). For lentivirus injection, 2 μl total volume was delivered into the dorsal hippocampus CA1 
region bilaterally at an average rate of 200 nl/min through a pulled capillary pipette connected to a Nanoject II 
(Drummond Scientific, Broomall, PA). CA1 injection coordinates were −1.6 mm from Bregma (AP), ± 1.48 mm 
to the midline (ML) and −1.48 mm ventral to the surface of the skull (DV). Stereotaxic coordinates were adjusted 
slightly to the weight of each mouse.
Immunohistochemistry. The brain slices were fixed in 4% paraformaldehyde, embedded in 4% agarose and 
sliced into 60 µm thick coronal sections by a vibratome (VT1000S, Leica, Germany). Sliced sections were blocked 
with 6% normal donkey serum (Bethyl Laboratories, Montgomery, TX) and were permeabilized with 0.3% Triton 
X-100 in phosphate-buffered saline (PBS) at 4 °C for 1 h and then were incubated with rabbit anti-GFP antibody 
(LF-PA0043, 1:1000, Ab frontier, South Korea) at 4 °C overnight. Brain slices were washed 3 times in PBS and 
donkey anti-rabbit Alexa 568 conjugated IgG antibody (A10042, 1:500, Invitrogen) was used at 4 °C overnight as 
a secondary antibody. All brain slices were washed 3 times in PBS, then mounted on the slide glass with UltraCruz 
mounting medium with DAPI (Santa Cruz, Dallas, TX).
Image acquisition and analysis. All fluorescence images were acquired with confocal microscopy 
(Olympus FV1000 or Zeiss LSM 510) using 10×, 40×, 63× objectives. Live cells were maintained at 35 °C during 
imaging in the live cell chamber (LCI, Korea) and treated with 100 nM rapamycin (LC laboratories) for 3 min. 
Images were exported from Fluoview viewer (Olympus, Japan) or Zen software (Zeiss, Germany) as TIFF files. 
Fluorescence intensity was analyzed with Metamorph software (Molecular Devices, Sunnyvale, CA).
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Electrophysiology. Mice were anesthetized with ketamine and xylazine mixture and then perfused tran-
scardially with an ice-cold sucrose slicing solution (20 mM NaCl, 3.5 mM KCl, 1.3 mM MgCl2, 1.4 mM NaH2PO4, 
26 mM NaHCO3, 11 mM Glucose and 175 mM sucrose). The brain was rapidly removed from the skull and placed 
in the same solution. Thereafter, coronal slices of the brain containing the hippocampus (400 μM) were made 
using a vibratome (VT1000s) in the ice-cold sucrose slicing solution, which was equilibrated with a gas mixture 
of 95% O2 and 5% CO2. The slices were maintained in oxygenated ACSF (119 mM NaCl, 2.5 mM KCl, 2.5 mM 
CaCl2, 1 mM MgSO4, 1.25 mM NaH2PO4, 26 mM NaHCO3 and 10 mM glucose) at room temperature for at least 
1 h before recording. Slices were transferred into a recording chamber and perfused with oxygenated ACSF at a 
rate of 2 ml/min. The brain slices were exposed 100 nM rapamycin (LC laboratories) for 3 min in the recording 
chamber with ACSF.
Whole-cell patch clamp recordings were made from pyramidal neurons in the CA1. Electrophysiological 
experiments were performed with Axopatch 200A (Molecular Devices). Data were acquired by pCLAMP 10.4 
software (Molecular Devices) and analyzed by Clampfit 10.4 (Molecular Devices). Recordings were under visual 
guidance using a Leica microscope with both transmitted light and epifluorescence illumination. Uninfected and 
infected neurons were distinguished base on the presence of fluorescence signal. Patch pipettes (8–10 MΩ) were 
pulled from borosilicate glass (1B150–4, World Precision Instruments, Sarasota, FL) by an electrode puller (PC-
10, Narishige, Japan).
Rheobase and action potentials rate were measured by current clamp mode with a K-gluconate based internal 
solution (120 mM K-gluconate, 5 mM NaCl, 1 mM MgCl2, 0.2 mM EGTA, 10 mM HEPES, 2 mM Mg-ATP and 
0.1 mM Na-GTP). For recording of evoked synaptic responses, a stimulating electrode was placed in the CA3 of 
the hippocampus approximately 0.1 mm from recorded cell bodies in the CA1 of the hippocampus. Recording 
electrodes were filled with a cesium methane sulfonate based internal solution (130 mM Cesium methane sul-
fonate, 10 mM HEPES, 0.5 mM EGTA, 8 mM NaCl and 10 mM phosphocreatine, 2 mM Mg-ATP, 0.1 mM Na-GTP 
and 5 mM QX-314). Bath solution contained 100 μM picrotoxin (PTX) to block GABAα receptor-mediated cur-
rent. The stimulus intensity was adjusted to evoke synaptic responses that have the amplitudes 35–40% of the 
maximum EPSC amplitudes. EPSC recording was obtained in the voltage-clamp mode with the cesium meth-
ane sulfonate based internal solution. AMPAR-mediated transmission was obtained as the peak amplitude of 
the EPSC recorded at −70 mV holding potential. NMDAR-mediated transmission was determined as EPSCs 
recorded at +40 mV holding potential at 50 ms after afferent stimulation. LTP was induced using a pairing pro-
tocol by stimulating Schaffer collateral fibers at 2 Hz (80 pulses), while depolarizing the postsynaptic neurons to 
0 mV. LTD was induced by low-frequency stimulation (LFS, 900 pulses at 1 Hz), while clamped at −70 mV.
Statistics. Quantitative data obtained from images are expressed as the mean ± SEM. Statistical analysis of 
electrophysiology results is expressed as mean ± SEM % of baseline amplitude of EPSCs recorded over at least a 
5 min baseline period. The numbers animals used (N) and/or experiments performed (n) are specified in the fig-
ure legends. The normality of the data was first tested by the Shapiro-Wilk test. Mann-Whitney U-test or unpaired 
t-test was used to determine statistical significance between two groups. *P < 0.05; **P < 0.01; or ***P < 0.001.
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